Private Equity
Available capital and promise of consumer staples keep sponsors around but most companies will not seal deals in the near term.
3 min read · 24 March 2020
While many traditional PE shops are busy assessing the potential impacts of covid-19 on their portfolios, a few are turning to their companies to develop vaccines and tests to curb the spread of coronavirus.
4 min read · 24 March 2020
The turnaround expert shares his take on covid-19's impact on PE, asserting that he's seeing MAC clauses implemented for the first time in his 20-year career.
6 min read · 23 March 2020
Imprivata, which helps healthcare providers protect patient information, was anticipated to command upwards of $2bn in a potential sale.
2 min read · 20 March 2020
Areas of the healthcare industry will likely be triggered into action, spurring innovation, as bottlenecks in the system become increasingly clear amid covid-19, Adams told PE Hub.
3 min read · 19 March 2020
Chris Gaffney, managing partner at Great Hill Partners, recently talked to PE Hub about priorities for the Boston-based firm amidst the pandemic.
3 min read · 19 March 2020
Coronavirus forces gym, yoga studios and other fitness centers to shutter shops, halting cash flow.
3 min read · 19 March 2020
The company’s business model is likely to remain resilient to a downturn triggered by the covid-19 outbreak, one of the sources said.
2 min read · 17 March 2020
Barclays and Moelis have been engaged for sell-side financial advice, however the timeline of the process is unclear amid market uncertainty.
3 min read · 17 March 2020
As the JPM and Rothschild process for the French nuclear medicine company is put on hold, attention shifts to Webster Equity-backed PharmaLogic, sources told PE Hub.
2 min read · 17 March 2020
